title: Do polycystic-appearing ovaries affect the risk of cardiovascular disease among women with polycystic ovary syndrome?
abstract: OBJECTIVE
  To determine if polycystic-appearing ovaries (PAO) are associated with differences in risk factors for cardiovascular disease among women with polycystic ovary syndrome (PCOS).
  
  
  METHODS
  Case-control sub-study.
  
  
  METHODS
  Division of Reproductive Endocrinology, Magee-Womens Hospital.
  
  
  METHODS
  Women with PCOS (n = 63) and non-PCOS controls (n = 56).
  
  
  METHODS
  Transvaginal ultrasonography and single sample venipuncture.
  
  
  METHODS
  Ultrasound ovarian appearance, fasting insulin, lipoproteins, androgens, LH/FSH ratio, anthropomorphic measurements, and blood pressure.
  
  
  RESULTS
  Women with PCOS had higher androgen and fasting insulin levels, a more adverse lipid profile, greater waist-hip and LH/FSH ratios, and a larger ovarian volume than controls. Thirty-three percent of the cases with PCOS, but only 5% of controls, showed PAO on ultrasound study (P<.01). PCOS cases with and without PAO had comparable levels of fasting insulin, lipids, and blood pressures. PCOS cases with PAO had a higher LH/FSH ratio (P=.028), increased levels of serum androstenedione (P=.029) and testosterone (P=.055), and greater ovarian volume (P=.024) compared to non-PAO patients.
  
  
  CONCLUSIONS
  Women with PCOS have greater cardiovascular risk than controls. Within PCOS cases, however, the ultrasound appearance of polycystic ovaries does not appear to further intensify the cardiovascular disease risk profile of these women.
authors.affiliation: Department of Epidemiology, University of Pittsburgh Graduate School of Public Health, Pittsburgh, Pennsylvania 15213, USA.
authors.forename: T L
authors.initials: TL
authors.lastname: Loucks
authors.forename: E O
authors.initials: EO
authors.lastname: Talbott
authors.forename: K P
authors.initials: KP
authors.lastname: McHugh
authors.forename: M
authors.initials: M
authors.lastname: Keelan
authors.forename: S L
authors.initials: SL
authors.lastname: Berga
authors.forename: D S
authors.initials: DS
authors.lastname: Guzick
mesh_terms: D000328:Adult; D001794:Blood Pressure; D002318:Cardiovascular Diseases / Q000150:complications*; D016022:Case-Control Studies; D002784:Cholesterol / Q000097:blood; D016208:Databases, Factual; D005260:Female; D006801:Humans; D008074:Lipoproteins / Q000097:blood; D010053:Ovary / Q000000981:diagnostic imaging / Q000473:pathology*; D011085:Polycystic Ovary Syndrome / Q000150:complications*; D012307:Risk Factors; D014463:Ultrasonography
chemical_list: D008074:Lipoproteins; D002784:Cholesterol